Medicare Enrolled

Dr. Carlos Sanchez, MD

Pulmonary Disease · Atlantis, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5401 S CONGRESS AVE STE 204, Atlantis, FL 33462
5619674118
In practice since 2006 (19 years)
NPI: 1134164395 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sanchez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sanchez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sanchez

Dr. Carlos Sanchez is a pulmonary disease in Atlantis, FL, with 19 years in practice. Based on federal Medicare data, Dr. Sanchez performed 4,039 Medicare services across 1,465 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sanchez received a total of $6,700 from 27 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sanchez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 10% volume in FL$ $6,700 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,039
Medicare services
Top 10% in FL for pulmonary disease
1,465
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~213 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity1,263$64$154
Nursing facility visit, moderate complexity893$82$194
Office visit, established patient (20-29 min)456$66$154
Remote patient monitoring management, 20 min/month198$39$107
Remote patient monitoring device, 30 days186$39$131
Office visit, established patient (30-39 min)183$96$226
Test to examine how well the lungs exchange gases158$42$114
Test to measure expiratory airflow and volume changes before and after medication administration156$29$127
Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes115$105$276
Test to determine lung volumes using gas dilution or washout110$34$92
Initial hospital admission, moderate complexity97$104$216
Inhalation treatment for airway obstruction or sputum production53$7$40
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes49$31$88
Initial hospital admission, high complexity43$139$427
New patient office visit (45-59 min)42$116$350
Hospital follow-up visit, high complexity37$97$222
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,700
Total received (2018-2024)
Avg $957/year across 7 years
Top 30% in FL for pulmonary disease
27
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,525 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$174 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,466
2023
$1,907
2022
$598
2021
$441
2020
$316
2019
$709
2018
$264

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,721
AstraZeneca Pharmaceuticals LP
$1,369
Inogen, Inc.
$413
United Therapeutics Corporation
$346
Actelion Pharmaceuticals US, Inc.
$329
Boehringer Ingelheim Pharmaceuticals, Inc.
$304
Mylan Specialty L.P.
$268
ShockWave Medical, Inc
$243
Takeda Pharmaceuticals U.S.A., Inc.
$211
ANI Pharmaceuticals, Inc.
$208
Insmed, Inc.
$192
INOGEN, INC.
$180
Mallinckrodt Hospital Products Inc.
$148
Regeneron Healthcare Solutions, Inc.
$120
Amgen Inc.
$105
Grifols USA, LLC
$96
Vifor Pharma, Inc.
$86
GENZYME CORPORATION
$68
Genentech USA, Inc.
$57
Axsome Therapeutics, Inc.
$51
Harmony Biosciences Llc
$49
Resmed Corp
$30
Intuitive Surgical, Inc.
$29
Covis Pharma GmBH
$21
Philips North America LLC
$19
OptiNose US, Inc.
$19
Apria Healthcare LLC
$17
Top 3 companies account for 52.3% of total payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · AREXVY · Arikayce · BREZTRI · DUPIXENT · Da Vinci Surgical System · Esbriet · FASENRA · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · Medela · NUCALA · OFEV · OPSUMIT · ORENITRAM · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMBICORT · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · WAKIX · Xhance · Xolair · YUPELRI · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $166 per 100 Medicare services performed
Looking for a pulmonary disease in Atlantis?
Compare pulmonary diseases in the Atlantis area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
56
Per 100K population
3.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sanchez is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sanchez experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Sanchez performed 1,263 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sanchez receive payments from pharmaceutical companies?
Yes. Dr. Sanchez received a total of $6,700 from 27 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sanchez's costs compare to other pulmonary diseases in Atlantis?
Dr. Sanchez's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sanchez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →